All news

Charles River Laboratories stock hits 52-week high

Alpha Vantage · Investing.com India · · AI-summarised by FinFlash

Charles River Laboratories (CRL) reached a new 52-week high of $378.24, gaining 108% over the past year and 128% over six months. The surge is backed by positive analyst revisions from UBS, Jefferies, Mizuho and TD Cowen, though InvestingPro data suggests the stock looks overvalued.

Read original source

CRL company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.